Evidence map›Paper›PMID 40573167›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Comprehensive GC-MS Profiling and Multi-Modal Pharmacological Evaluations of

Iram Iqbal, Mohamed A M Ali, Fatima Saqib, Kinza Alamgir, Mohammad S Mubarak, Anis Ahmad Chaudhary, Mohamed El-Shazly, Heba A S El-Nashar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iram IqbalDepartment of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.ORCID 0009-0007-6186-9374
Mohamed A M AliDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.ORCID 0000-0001-8217-0262
Fatima SaqibDepartment of Pharmacology, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.ORCID 0000-0001-6242-7147
Kinza AlamgirDepartment of Bioinformatics and Biotechnology, Government College University Faisalabad (GCUF), Faisalabad 38000, Pakistan.
Mohammad S MubarakDepartment of Chemistry, The University of Jordan, Amman 11942, Jordan.ORCID 0000-0002-9782-0835
Anis Ahmad ChaudharyDepartment of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 11623, Saudi Arabia.ORCID 0000-0002-1506-7836
Mohamed El-ShazlyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.
Heba A S El-NasharDepartment of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt.ORCID 0000-0003-4252-7647

Funding

Imam Mohammad ibn Saud Islamic University IMSIU-DDRSP2501
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ADMEantidiarrhealcalcium channel blockerGCMSHaloxylon griffithiispasmolytic

Identifiers

PMID40573167
PMCPMC12195856

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.